Xenon Pharmaceuticals
Price & Volume
Stats
See moreOpen | $40.40 |
Previous Close | $39.80 |
Day Range | $40.22-$40.88 |
52W Range | $29-$50.99 |
Market Cap | $2.9B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$96.3M |
Diluted EPS | -$2.81 |
News
See moreYahoo Finance • 12 months ago
Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
Yahoo Finance • 12 months ago
Xenon Pharmaceuticals Announces Proposed Public Offering
Yahoo Finance • 12 months ago
Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)
Yahoo Finance • last year
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2023 Earnings Call Transcript
About
CEO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
Address | 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 251 |
